XAIR Price / FCF | Beyond Air, Inc.

Beyond Air, Inc. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

Beyond Air, Inc. price-fcf ratio for the quarter ending 2026-06-30 was -0.02, a change of 0.01 year-over-year.
Beyond Air, Inc. price-fcf ratio for the quarter ending 2026-03-31 was -0.02, a change of 10.2 year-over-year.
Beyond Air, Inc. price-fcf ratio for the quarter ending 2025-12-31 was -0.28, a change of 220.7 year-over-year.
Beyond Air, Inc. price-fcf ratio for the quarter ending 2025-09-30 was -0.71, a change of 202.3 year-over-year.
Beyond Air, Inc. price-fcf ratio for fiscal 2026 was -0.02.
Beyond Air, Inc. price-fcf ratio for fiscal 2025 was -0.28, a change of 220.7 from fiscal 2024.
Beyond Air, Inc. price-fcf ratio for fiscal 2024 was -220.98, a change of 245.99 from fiscal 2023.
Beyond Air, Inc. price-fcf ratio for fiscal 2023 was -466.97, a change of 1,780.66 from fiscal 2022.

Available history: 2019-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-0.02	$317,439.49	-$19.6M
2026-03-31	-0.02	$408,325.01	-$19.17M
2025-12-31	-0.28	$6.18M	-$22.13M
2025-09-30	-0.71	$18.58M	-$26.15M
2025-06-30	-0.02	$805,836.86	-$35.97M
2025-03-31	-10.22	$450.84M	-$44.1M
2024-12-31	-220.98	$10.67B	-$48.3M
2024-09-30	-203.01	$11.2B	-$55.19M
2024-06-30	-174	$9.86B	-$56.66M
2024-03-31	-517.28	$31.95B	-$61.76M
2023-12-31	-466.97	$27.81B	-$59.57M
2023-09-30	-551.63	$29.54B	-$53.56M
2023-06-30	-1,131.98	$54.04B	-$47.74M
2023-03-31	-2,250.02	$82.99B	-$36.89M
2022-12-31	-2,247.62	$77.92B	-$34.67M
2022-09-30	-4,532.14	$89.02B	-$19.64M
2022-06-30	-15,834.55	$79.98B	-$5.05M
2022-03-31	-42,073.69	$79.86B	-$1.9M
2021-12-31	140,844.53	$106.34B	$755,000.00
2021-09-30	-10,649.92	$112.13B	-$10.53M
2021-06-30	-3,217.38	$60.31B	-$18.75M
2021-03-31	-2,339.23	$48.02B	-$20.53M
2020-12-31	-1,955.49	$38.75B	-$19.81M
2020-09-30	-1,856.58	$35.61B	-$19.18M
2020-06-30	-2,696.93	$48.84B	-$18.11M
2020-03-31	-3,359.58	$51.38B	-$15.29M
2019-12-31	-8,723.73	$29.08B	-$3.33M
2019-09-30	-88,691.07	$19.78B	-$223,003.00

Annual Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-0.02	$317,439.49	-$19.6M
2025-12-31	-0.28	$6.18M	-$22.13M
2024-12-31	-220.98	$10.67B	-$48.3M
2023-12-31	-466.97	$27.81B	-$59.57M
2022-12-31	-2,247.62	$77.92B	-$34.67M
2021-12-31	140,844.53	$106.34B	$755,000.00
2020-12-31	-1,955.49	$38.75B	-$19.81M
2019-12-31	-8,723.73	$29.08B	-$3.33M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Vivos Therapeutics, Inc. (VVOS)	United States	$0.003B	-0.26
NEXGEL, INC. (NXGL)	United States	$0.002B
INVO Fertility, Inc. (IVF)	United States	$0.002B	-0.71
Catheter Precision, Inc. (VTAK)	United States	$0.002B	-0.23
Autonomix Medical, Inc. (AMIX)	United States	$0.004B
Adagio Medical Holdings, Inc. (ADGM)	United States	$0.004B
Tenon Medical, Inc. (TNON)	United States	$0.002B
OSR Health, Inc. (OSRH)	United States	$0.004B	-0.75
Profusa, Inc. (PFSA)	United States	$0.002B
Bluejay Diagnostics, Inc. (BJDX)	United States	$0.004B